Fact CheckerSign in

NCT05540457Completed

Evaluation of Non-Invasive Continuous vs Intermittent BloodPressure Monitors in Maintenance Dialysis (BP Dialysis)

Evaluation of Non-Invasive Continuous vs Intermittent BloodPressure Monitors in Maintenance Dialysis

Source: ClinicalTrials.gov · Last updated 11 Jun 2025

Brief summary (registry, in English)

Prospective, single center, open label, non-randomized, post-market study of the Tablo Hemodialysis System and VitalStream Monitor in participants with End-Stage KidneyDisease undergoing In-Center Hemodialysis.

Status (registry)
Completed
Study type
Interventional
Enrollment
10 (actual)
First submitted
10 Aug 2022
Start date
22 Sept 2022
Primary completion date
9 Feb 2024
Lead sponsor
The Rogosin Institute
NCT number
NCT05540457

What you commit to

  • Study type: Interventional
  • Participants enrolled: 10
  • From 22 Sept 2022 to the primary completion date, 9 Feb 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Participant has lack of perfusion of the digitalarteries and arterioles in the lower arm and hand.
  • The Non-Invasive Blood Pressure (NIPB) monitorcuffs (finger and/or brachial) are unable to becorrectly sized to the participant.

Who the study is looking for

  • Participant is at least 18 years of age and has provided informed consent and has signed a Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant authorization statement.
  • Participant weighs ≥ 34kg.
  • Participant has end stage kidney disease (ESKD) adequately treated by maintenance dialysis.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
The Rogosin Institute
Coordinator of this site? Confirm its status		New YorkUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.